Investors
Opyl is headquartered in Melbourne, Australia and listed on the Australian Stock Exchange (ASX:OPL)
ASX Announcements
Opyl partners with leading patient advocate groups
downloadOpyl signs two clinical trial recruitment contracts
downloadOpyl receives $361K R&D tax refund
downloadOpyl Director Mr Basyrov steps down
downloadNotice of 2021 Annual General Meeting
downloadOpyl to present at next week’s IRD Invest
downloadQuarterly Reports
Opyl Appendix 4C – Quarter (Q4) ending 30 June 2022
downloadOpyl Appendix 4C – Quarter (Q3) ending 31 March 2022
downloadOpyl Appendix 4D – Half-year ending 31 December 2021
downloadOpyl Appendix 4C – Quarter (Q2) ending 31 December 2021
downloadOpyl Appendix 4C – Quarter (Q1) ending 30 September 2021
downloadOpyl Appendix 4C – Quarter (Q4) ending 30 June 2021
downloadCorporate Governance
Opyl – Corporate Governance Statement 2021
downloadOpyl – Audit and Risk Committee Charter 2020
downloadOpyl – Board Charter 2020
downloadOpyl – Code of Conduct 2020
downloadOpyl – Diversity Policy 2020
downloadOpyl – Remuneration and Nomination Committee Charter 2020
downloadOpyl – Trading Policy 2020
downloadOpyl – Whistleblower 2020
downloadOpyl – Disclosure and Communication Policy 2020
downloadBoard and Management Team
Dr Julian Chick
Chairman
Michelle Gallaher
Chief Executive Officer
Damon Rasheed
Executive Director
Mark Ziirsen
Non Executive Director
Dr Megan Robertson
Non Executive Director
David Iilja
Company Secretary